Pfizer expects to file for full US Food and Drug Administration approval of its Covid-19 vaccine for 16-to-85-year-olds by the end of May, the company said during its first quarter 2021 earning teleconference Tuesday.
“While we are currently distributing our vaccine in the US under an Emergency Use Authorization (EUA), we expect to submit this month a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) seeking full approval for our Covid-19 vaccine for individuals 16 years of age and older,” Pfizer CEO Albert Bourla said in his remarks.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
CLOGSAG vows to resist partisan appointments in Civil, Local Government Service
43 minutes -
Peasant Farmers Association welcomes Mahama’s move to rename Agric Ministry
45 minutes -
NDC grateful to chiefs, people of Bono Region -Asiedu Nketia
47 minutes -
Ban on smoking in public: FDA engages food service establishments on compliance
48 minutes -
Mahama’s administration to consider opening Ghana’s Mission in Budapest
50 minutes -
GEPA commits to building robust systems that empower MSMEs
52 minutes -
Twifo Atti-Morkwa poultry farmers in distress due to high cost of feed
54 minutes -
Central Region PURC assures residents of constant water, power supply during yuletide
56 minutes -
Election victory not licence to misbehave – Police to youth
57 minutes -
GPL 2024/2025: Nations thrash struggling Legon Cities
60 minutes -
Electoral offences have no expiry date, accountability is inevitable – Fifi Kwetey
1 hour -
Ghanaians to enjoy reliable electricity this Christmas – ECG promises
1 hour -
Police deny reports of election-related violence in Nsawam Adoagyiri
1 hour -
‘We’re not brothers; we’ll show you where power lies’ – Dafeamekpor to Afenyo-Markin
1 hour -
EPA says lead-based paints are dangerous to health, calls for safer alternatives
3 hours